论文信息 - 46P AB521, a clinical-stage, potent, and selective Hypoxia-Inducible Factor (HIF)-2α inhibitor, for the treatment of renal cell carcinoma - 字舞流文

46P AB521, a clinical-stage, potent, and selective Hypoxia-Inducible Factor (HIF)-2α inhibitor, for the treatment of renal cell carcinoma

F. Soriano | A. Mailyan | L. Seitz | M. Leleti | K. Liao | J. Fournier | K. Lawson | E. Ginn | C. Meleza | M. Walters | G. Mata | K. Yu | L. Jin | E. Paterson | P. Schweickert | D. Piovesan | P. Foster | A. Pham | S. Liu | K.E. Sivick Gauthier